Participating trials
The ATCG is a collaboration between different clinical trials carried out all over the world. The collaboration exists of the following clinical trials:
- ADD-ASPIRIN trial: Principal Investigator Ruth Langley
- ALASCCA trial: Principal Investigator Anna Martling
- ASCOLT trial: Principal Investigators John Chia and Eva Segelov
- ASAC trial: Principal Investigators Bjørn Atle Bjørnbeth, Kjetil Tasken and Sheraz Yaqub
- ASPIRIN trial: Principal Investigators Gerrit-Jan Liefers, Johanneke Portielje and Ricardo Fodde
- ASPIRIN trial Belgium: Principal Investigator Marc Peeters
- SAKK 41/13-Aspirin: Principal Investigator Ulrich Güller